The effect of low molecular weight heparin on survival in cancer patients: an updated systematic review and meta-analysis of randomized trials

The efficacy and safety of low-molecular-weight heparin use for cancer treatment: A meta-analysis

(2013) D.H. Che et al.   European Journal of Internal Medicine

Adjuvant therapy with bemiparin in patients with limited-stage small cell lung cancer: Results from the ABEL study

(2013) R. Lecumberri et al.   THROMBOSIS RESEARCH

Low-Molecular-Weight Heparin Versus Placebo for the Prevention of Venous Thromboembolism in Metastatic Breast Cancer or Stage III/IV Lung Cancer

(2012) Sylvia K. Haas et al.   CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS

Semuloparin for Thromboprophylaxis in Patients Receiving Chemotherapy for Cancer

(2012) Giancarlo Agnelli et al.   NEW ENGLAND JOURNAL OF MEDICINE

Venous thromboembolism in cancer patients – Risk scores and recent randomised controlled trials

(2012) Cihan Ay et al.   THROMBOSIS AND HAEMOSTASIS

The use of extended perioperative low molecular weight heparin (tinzaparin) to improve disease-free survival following surgical resection of colon cancer

(2011) Rebecca Auer et al.   BLOOD COAGULATION & FIBRINOLYSIS

Gemcitabine versus gemcitabine plus dalteparin thromboprophylaxis in pancreatic cancer

(2011) A. Maraveyas et al.   EUROPEAN JOURNAL OF CANCER

Randomized Trial of the Effect of the Low Molecular Weight Heparin Nadroparin on Survival in Patients With Cancer

(2011) Frederiek F. van Doormaal et al.   JOURNAL OF CLINICAL ONCOLOGY

Effet de la tinzaparine sur la mortalité du cancer bronchique non à petites cellules opéré

(2011) G. Meyer et al.   REVUE DES MALADIES RESPIRATOIRES

Cooperation of tissue factor cytoplasmic domain and PAR2 signaling in breast cancer development

(2010) F. Schaffner et al.   BLOOD

PRODIGE: a randomized placebo-controlled trial of dalteparin low-molecular-weight heparin thromboprophylaxis in patients with newly diagnosed malignant glioma

(2010) J. R. PERRY et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Extended prophylaxis with bemiparin for the prevention of venous thromboembolism after abdominal or pelvic surgery for cancer: the CANBESURE randomized study

(2010) V. V. KAKKAR et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

FRAGMATIC: A randomised phase III clinical trial investigating the effect of fragmin® added to standard therapy in patients with lung cancer

(2009) Gareth O Griffiths et al.   BMC CANCER

Impact of Venous Thromboembolism and Anticoagulation on Cancer and Cancer Survival

(2009) Nicole M. Kuderer et al.   JOURNAL OF CLINICAL ONCOLOGY

Nadroparin for the prevention of thromboembolic events in ambulatory patients with metastatic or locally advanced solid cancer receiving chemotherapy: a randomised, placebo-controlled, double-blind study

(2009) Giancarlo Agnelli et al.   LANCET ONCOLOGY

Alternatively spliced tissue factor induces angiogenesis through integrin ligation

(2009) Y. W. van den Berg et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Efficacy and safety of enoxaparin in Japanese patients undergoing curative abdominal or pelvic cancer surgery: Results from a multicenter, randomized, open-label study

(2009) Masato Sakon et al.   THROMBOSIS RESEARCH